Correlation Between UBS ETF and BB Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both UBS ETF and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UBS ETF and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between UBS ETF MSCI and BB Biotech AG, you can compare the effects of market volatilities on UBS ETF and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UBS ETF with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of UBS ETF and BB Biotech.

Diversification Opportunities for UBS ETF and BB Biotech

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between UBS and BION is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding UBS ETF MSCI and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and UBS ETF is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UBS ETF MSCI are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of UBS ETF i.e., UBS ETF and BB Biotech go up and down completely randomly.

Pair Corralation between UBS ETF and BB Biotech

Assuming the 90 days trading horizon UBS ETF MSCI is expected to generate 0.53 times more return on investment than BB Biotech. However, UBS ETF MSCI is 1.9 times less risky than BB Biotech. It trades about 0.05 of its potential returns per unit of risk. BB Biotech AG is currently generating about -0.04 per unit of risk. If you would invest  1,741  in UBS ETF MSCI on August 24, 2024 and sell it today you would earn a total of  253.00  from holding UBS ETF MSCI or generate 14.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

UBS ETF MSCI  vs.  BB Biotech AG

 Performance 
       Timeline  
UBS ETF MSCI 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days UBS ETF MSCI has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, UBS ETF is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
BB Biotech AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

UBS ETF and BB Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with UBS ETF and BB Biotech

The main advantage of trading using opposite UBS ETF and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UBS ETF position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.
The idea behind UBS ETF MSCI and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios